NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE130385 Query DataSets for GSE130385
Status Public on May 12, 2021
Title Temporal transcriptional response from primary human chronic lymphocytic leukemia (CLL)-cells after B-cell receptor stimulation.
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Summary The B-cell receptor (BCR) signaling is crucial for the pathophysiology of most leukemias and lymphomas originated from mature B lymphocytes and has emerged as a new therapeutic target, especially for chronic lymphocytic leukemia (CLL). However, the precise mechanisms by which BCR signaling controls neoplastic B-cell proliferation are ill characterized. This work was performed using primary leukemic cells of untreated patients at initial stage of CLL (Binet stage A / Rai 0) presenting biological characteristics of aggressive form of the disease (unmutated IGHV genes and ZAP70 protein expression). In order to mimic the primary leukemogenic step occurring in vivo, this study focused on the BCR-dependent proliferation of CLL cells induced ex vivo using anti-IgM, together with mandatory co-stimulating factors (CD40L, IL-4 and IL-21) (Schleiss, Sci Rep, 2019). Cell proliferation was objectivized by the emergence of proliferative clusters and the presence of more than 25% of CLL cells that did undergo division within the cell culture at day 6. To capture the specific actors of the proliferative response in these samples, we also included non-proliferating control CLL samples. Gene expression was analyzed by RNA-seq before stimulation (T0) and at the time points 1h, 1h30, 3h30, 6h30, 12h, 24h, 48h and 96h after cell stimulation (n=54 data points), the latest time points corresponding to the emergence of the proliferation clusters.
 
Overall design Temporal transcriptional response (T0 + 8 time points) of primary chronic lymphocytic leukemia (CLL) cells after BCR engagement ex vivo (anti-IgM, IL-4, CD40Ligand and IL-21) of 3 Proliferating (P1, P2, P3) and 3 Non Proliferating samples (NP1, NP2, NP3).
 
Contributor(s) Schleiss C, Carapito R, Vallat L
Citation(s) 33833385
Submission date Apr 26, 2019
Last update date May 12, 2021
Contact name Laurent Vallat
E-mail(s) vallat@unistra.fr
Organization name Strasbourg University Hospital
Department Hematology
Lab INSERM UMR-S1113
Street address 1, avenue Molière
City Strasbourg
ZIP/Postal code 67200
Country France
 
Platforms (1)
GPL17303 Ion Torrent Proton (Homo sapiens)
Samples (54)
GSM3737237 CLL_NP1_0
GSM3737238 CLL_NP1_1
GSM3737239 CLL_NP1_2
Relations
BioProject PRJNA539961
SRA SRP193987

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE130385_Raw_counts.csv.gz 1.5 Mb (ftp)(http) CSV
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap